NICE publishes new standards to develop digital health technology
New standards, published today, set out the requirements needed to develop digital health technologies for the NHS and speed uptake of products like healthcare...
New mitral valve repair procedure given the go-ahead
An innovative procedure which repairs a heart valve has been approved for use in the NHS for patients who would otherwise be unable to...
NHS Digital takes major step on road to universal electronic prescriptions
NHS Digital has launched a pilot in what is being called a major step on the road to universal electronic prescriptions. The pilot could...
Assessing progress on cancer care in England
The Health Foundation, in collaboration with Professor Sir Mike Richards, has published a major report today assessing progress on cancer care in England over...
Generation Z want digital solutions to revolutionise the NHS
An overwhelming majority of 16 to 24 year olds – 82% – want to see digital solutions to revolutionise the NHS. Generation Z expect a...
7000 under 25’s have type 2 diabetes in England and Wales
Diabetes UK have reported that there are nearly 7000 young people with type 2 diabetes in England and Wales, almost 10 times the amount...
Access to medicine after Brexit: Lords ask Minister for clarity
The House of Lords EU Home Affairs Sub-Committee has written to Matt Hancock MP, Secretary of State for Health and Social Care asking for...
Using data to reduce the risk of stroke
People with irregular and abnormally fast heart rates caused by atrial fibrillation could be at a greater risk of stroke and bleeding because they...
The Burden of Atrial Fibrillation: Understanding the Impact
Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation has today, during AF Association...
Pancreatic Cancer Story: John William Street
Pancreatic cancer is the 10th most common cancer in the UK, with around 9600 people diagnosed each year. The disease has the lowest survival...
Latest articles
IMBRUVICA® misses primary endpoint in pancreatic cancer trial
AbbVie have released an update on the RESOLVE trial of IMBRUVICA® in combination with chemotherapy agents in metastatic pancreatic cancer. AbbVie, a research-based global biopharmaceutical company,...
Star Europe’s Amsterdam office off to positive start
Star Europe has reported good feedback in the Netherlands since opening its Amsterdam office in November. Supported by established resources and infrastructure, the team at...
EC approves Vertex’s ORKAMBI® for cystic fibrosis patients
Vertex Pharmaceuticals announces that the European Commission has granted approval of the label extension for ORKAMBI® for cystic fibrosis patients. The European Commission has granted approval...